Suppr超能文献

手术后持续高水平的血清癌胚抗原水平表明 I 期非小细胞肺癌患者预后不良。

Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.

机构信息

Department of Surgery, Division of Thoracic Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.

出版信息

J Surg Res. 2010 Oct;163(2):e45-50. doi: 10.1016/j.jss.2010.04.039. Epub 2010 May 21.

Abstract

BACKGROUND

The aim of this study is to evaluate the prognostic significance of preoperative and postoperative serum carcinoembryonic antigen (CEA) levels in patients with stage I non-small-cell lung cancer.

MATERIAL AND METHODS

A retrospective review of the medical records of 257 patients with stage I lung cancer undergoing surgical resection was performed. The clinical data of each patient was collected for analysis including age, smoking habits, gender, preoperative and postoperative serum CEA levels, tumor diameter, histologic type, visceral pleural invasion, pathologic stage, and type of operation.

RESULTS

Adenocarcinoma was more often associated with elevated preoperative CEA level compared with non-adenocarcinoma. Tumor histology, however, did not influence postoperative CEA levels. In the univariate analysis, age, serum CEA level, and pathologic stage were prognostic factors. Patients with normal preoperative serum CEA levels had better 5-y survival than patients with high preoperative serum CEA levels (71.1% versus 54.6%, P = 0.016). The patients with a persistently high serum CEA level after surgery had worst prognosis. Multivariate analysis demonstrated that older age (≥65) and persistently high serum CEA levels were independent significant prognostic factors in patients with stage I lung cancer.

CONCLUSIONS

Age (≥65 years) and preoperative and postoperative serum CEA levels are independent prognostic factors in patients with stage I lung cancer. Patients with a persistently high serum CEA level after surgery had worst survival, and may be good candidates for adjuvant chemotherapy.

摘要

背景

本研究旨在评估术前和术后血清癌胚抗原(CEA)水平在 I 期非小细胞肺癌患者中的预后意义。

材料与方法

对 257 例接受手术切除的 I 期肺癌患者的病历进行回顾性分析。收集每位患者的临床资料进行分析,包括年龄、吸烟习惯、性别、术前和术后血清 CEA 水平、肿瘤直径、组织学类型、内脏胸膜侵犯、病理分期和手术类型。

结果

腺癌患者术前 CEA 水平升高的比例高于非腺癌患者。然而,肿瘤组织学并不影响术后 CEA 水平。单因素分析显示,年龄、血清 CEA 水平和病理分期是预后因素。术前血清 CEA 水平正常的患者 5 年生存率优于术前血清 CEA 水平升高的患者(71.1%比 54.6%,P=0.016)。术后持续高血清 CEA 水平的患者预后最差。多因素分析表明,年龄(≥65 岁)和持续高血清 CEA 水平是 I 期肺癌患者独立的显著预后因素。

结论

年龄(≥65 岁)和术前及术后血清 CEA 水平是 I 期肺癌患者的独立预后因素。术后持续高血清 CEA 水平的患者生存最差,可能是辅助化疗的良好候选者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验